Contact this trialFirst, we need to learn more about you.
Cancer Vaccine
SurVaxM + Temozolomide for Glioblastoma
Recruiting0 awardsPhase 2
New York, New York
This trial is testing if adding SurVaxM to standard chemotherapy helps patients with newly diagnosed glioblastoma live longer. SurVaxM works by boosting the immune system to fight cancer more effectively. SurVaxM is a vaccine developed for patients with malignant gliomas.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.